Syntara Limited (ASX:SNT) Announces Positive Phase 2 Trial Results
Syntara Limited reports positive interim data from its Phase 2 trial of SNT-5505, indicating potential as a breakthrough treatment for myelofibrosis.
Syntara Limited (ASX:SNT) Presents Interim Data from SNT-5505 Trial
Positive interim data from Syntara Limited’s SNT-5505 trial in myelofibrosis indicates significant clinical potential.
Riversgold Limited (ASX:RGL) Submits Mining Lease Application
Riversgold Limited (ASX:RGL) has submitted a Mining Lease application for the Northern Zone Gold Project, enhancing its development prospects.
BrainChip Holdings Ltd (ASX:BRN) Secures US$1.8 Million Contract
BrainChip Holdings Ltd secures a US$1.8 million contract from the Air Force Research Laboratory for radar signal processing development.
OpenLearning Limited (ASX: OLL) Announces Voluntary Suspension
OpenLearning Limited (ASX: OLL) has announced a voluntary suspension of its securities pending a key announcement regarding a related party loan facility.
Korvest Ltd (ASX:KOV) Reports Record Order Book for FY25
Korvest Ltd (ASX:KOV) forecasts a record order book and increased project work expected to drive significant profits in FY25.
Korvest Ltd (ASX:KOV) Announces Pause in Trading
Korvest Ltd (ASX:KOV) has temporarily paused trading of its securities pending a further announcement.
Immutep Limited (ASX: IMM) Initiates Phase III Trial for Lung Cancer
Immutep Limited (ASX: IMM) has announced the initiation of TACTI-004, a Phase III trial for first-line metastatic non-small cell lung cancer.
Integral Diagnostics (ASX: IDX) Provides Merger Update
Integral Diagnostics receives ACCC clearance for its merger with Capitol Health, expecting implementation by 20 December 2024.
James Bay Minerals Limited (ASX:JBY) Discovers High-Grade Copper and Silver at Independence Project
James Bay Minerals (ASX:JBY) announces high-grade copper and silver discoveries at its Independence Project, expanding its exploration targets.